Neurona Therapeutics Receives $23,500,000 Series A Round

  • Feed Type
  • Date
    12/2/2015
  • Company Name
    Neurona Therapeutics
  • Mailing Address
    650 Gateway Blvd South San Francisco, CA 94080 USA
  • Company Description
    Neurona Therapeutics is a pre-clinical stage biotechnology company that was founded by four leading-edge neuroscientists and stem cell pioneers at The University of California, San Francisco. We are focused on the discovery and development of cell-based therapies to treat intractable neurological disease.
  • Website
    http://www.neuronatherapeutics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $23,500,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    The Column Group
  • Venture Investor
    Undisclosed